Jonathan Goldstein

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Lifestyle Intervention for Pre-Diabetic Neuropathy

A. Gordon Smith, James W. Russell, Eva L. Feldman et al. · Diabetes Care · 2006 · 582 citations · Full text

Medicine, Neurology, Neuroscience +16

The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy

Steven Novella, Silvio E. Inzucchi, Jonathan Goldstein · Muscle & Nerve · 2001 · 248 citations · Full text

Medicine, Endocrinology, Neurology +11

Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry

Colleen Kelly, Eugene F. Yen, Ari Grinspan et al. · Gastroenterology · 2020 · 207 citations · Full text

Life Sciences, Immunology, Microbiology +15

Response of patients with refractory myasthenia gravis to rituximab: a retrospective study

Richard J. Nowak, Daniel DiCapua, Nazlee Zebardast et al. · Therapeutic Advances in Neurological Disorders · 2011 · 157 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16